✦ LIBER ✦

P1067 RESPONSE-GUIDED PEGINTERFERON ALFA-2a (PegIFN alfa-2a) THERAPY IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B (CHB)

✍ Scribed by Hou, J.; Ma, H.; Sun, J.; Xie, Q.; Xie, Y.; Sun, Y.; Wang, H.; Shi, G.; Wan, M.; Niu, J.; Ning, Q.; Yu, Y.; Xie, Y.

Book ID: 122312705
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 76 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)61227-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

712 EFFICACY AND SAFETY OF PEGINTERFERON

712 EFFICACY AND SAFETY OF PEGINTERFERON ALFA-2A IN CHINESE PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B

✍ D.-Z. Xu; Y. Xie; L. Wei; X.-Y. Chen; M.-B. Wan; Y.-M. Wang; L. Wang; J. Wei; J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 58 KB

HBeAg and hepatitis B virus DNA as outco

HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B

✍ Michael W. Fried; Teerha Piratvisuth; George K. K. Lau; Patrick Marcellin; Wan-C 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 414 KB 👁 2 views

The aims of this study were to evaluate the usefulness of quantitative hepatitis B e antigen (HBeAg) values for predicting HBeAg seroconversion in patients treated with peginterferon alfa-2a and to assess the dynamic changes in quantitative HBeAg during therapy, compared with conventional measures o

Peginterferon alfa-2B and lamivudine com

Peginterferon alfa-2B and lamivudine combination therapy compared with peginterferon alfa-2B for chronic hbeag-positive hepatitis B: A randomized controlled trial in 307 patients

📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Randomised clinical trial: efficacy of p

Randomised clinical trial: efficacy of peginterferon alfa-2a in HBeAg positive chronic hepatitis B patients with lamivudine resistance

✍ J. Sun; J.-L. Hou; Q. Xie; X.-H. Li; J.-M. Zhang; Y.-M. Wang; H. Wang; J.-Y. Lai 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

O115 PEGINTERFERON LAMBDA FOR THE TREATM

O115 PEGINTERFERON LAMBDA FOR THE TREATMENT OF CHRONIC HEPATITIS B (CHB): A PHASE 2B COMPARISON WITH PEGINTERFERON ALFA IN PATIENTS WITH HBeAg-POSITIVE DISEASE

✍ Chan, H.L.; Ahn, S.H.; Chang, T.-T.; Peng, C.-Y.; Wong, D.; Coffin, C.S.; Lim, S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

PIN55 Cost-Effectiveness Analysis of Peg

PIN55 Cost-Effectiveness Analysis of Peginterferon Alfa-2A (40KD) in HBEAG-Positive Chronic Hepatitis B in Poland

✍ M. Jakubczyk; J. Pawęska; M. Niewada; H. Berak; M. Szkultecka-Dębek; M. Russel-S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB